| General Information | |||
|---|---|---|---|
| Term | Danon disease | ID (Ontology) | DOID:0050437 (Human Disease) |
| Definition | A lysosomal storage disease that is characterized by cardiomyopathy, skeletal myopathy and intellectual disability and has_material_basis_in mutations in the LAMP2 gene. | ||
| Also Known As | "ANTOPOL DISEASE" ; "PSEUDOGLYCOGENOSIS II" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
X-linked monogenic disease |__X-linked dominant disease__ inherited metabolic disorder | |__lysosomal storage disease__| Danon disease 1 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a |
X-linked dominant disease lysosomal storage disease |
||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:9730 MESH:D052120 MIM:300257 NCI:C84735 SNOMEDCT_US_2023_03_01:419097006 UMLS_CUI:C0878677 |
|||